Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Watson Pharma Fentanyl Buccal tablets
Watson Pharma said that the approved drug is generic equivalent to Cephalon’s Fentora tablets. Fentora is used to treat breakthrough pain in adult patients with cancer (18 years
Watson Pharma said that the approved drug is generic equivalent to Cephalon’s Fentora tablets. Fentora is used to treat breakthrough pain in adult patients with cancer (18 years
Emerald and UCB had initiated their collaboration partnership in January 2009. Under the agreement, both the companies have identiified a series of small molecules and have solved high-resolution
Fentanyl immediate-release transmucosal medications are administered on the soft surfaces of the mouth or the nasal passages or throat where they dissolve and are absorbed. Abstral is indicated
Under the agreement, TD2 – a subsidiary of Translational Genomics Research Institute (TGen), will be the exclusive development partner for Oncoholdings’ oncology portfolio. The company plans to develop
UCB has initiated a new Phase III study assessing brivaracetam as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. The randomised, double-blind, placebo-controlled,
The ‘LifeSciencesUK’ is expected to allow biotechnology, pharmaceuticals, medical devices and diagnostics sectors to jointly funtion smoothly to better investment environment in the UK, reported Pharmacy Europe. ‘LifeSciencesUK’
The study will recruit around 200 patients and will evaluate the safety, tolerability and antiviral activity of CMX001. The primary objective of CMX001 study is to provide CMX001
Anticalins are recombinantly engineered lipocalins, endogenous low-molecular weight human proteins that naturally bind, store and transport a wide spectrum of molecules. The tie up includes an option of
Earlier, on 23 September 2010, the FDA and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of
According to the pact, Akrimax Pharma got license from NovaDel Pharma for the manufacturing and commercialization of NitroMist in North America. NovaDel Pharma’s NitroMist (nitroglycerin sublingual spray) belongs